Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database (Q33321434)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

HIV transmission

0 references

anti-retroviral agent

0 references

0 references

0 references

Kristel Van Laethem

9

object named as

Kristel Van Laethem

0 references

François Roman

2

object named as

François Roman

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Jean-Claude Schmit

12

object named as

Jean-Claude Schmit

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Jean Ruelle

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Anne-Thérèse Vandenbroucke

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Christine Lambert

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Katrien Fransen

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Fedoua Echahidi

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Denis Piérard

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Chris Verhofstede

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Marie-Luce Delforge

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dolorès Vaira

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Patrick Goubau

13

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Natural polymorphisms of HIV type 2 pol sequences from drug-naive individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Global epidemiology of HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Highly active antiretroviral therapy and viral response in HIV type 2 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Development of a real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Quantification of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p24 antigen detection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Resistance to nucleoside analogs of selective mutants of human immunodeficiency virus type 2 reverse transcriptase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Human immunodeficiency virus type 2 infection associated with AIDS in West Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

21 June 2018

Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

Quantitative detection of plasma human immunodeficiency virus type 2 subtype A RNA by the Nuclisens EasyQ Assay (version 1.1).

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

Rapid progression of CD4 cell decline and subsequent response to salvage therapy in HIV-2 infection

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

Long-term intrapatient viral evolution during HIV-2 infection

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

HIV-2 Protease resistance defined in yeast cells

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

Genetic polymorphisms and resistance mutations of HIV type 2 in antiretroviral-naive patients in Burkina Faso

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

Quantitative real-time PCR on Lightcycler for the detection of human immunodeficiency virus type 2 (HIV-2).

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

HIV-1 and HIV-2 prevalence and associated risk factors among postnatal women in Harare, Zimbabwe

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a Brome Mosaic Virus internal control

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-21

21 January 2018

Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

31 October 2018

Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

31 October 2018

Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

31 October 2018

Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

31 October 2018

Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

31 October 2018

Cellular and plasma viral load in patients infected with HIV-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292191

31 October 2018

Comparative analysis of the sequences and structures of HIV-1 and HIV-2 proteases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18304321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Efficacy and tolerance of antiretroviral therapy in HIV-2 infected patients in Dakar: preliminary study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18304321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-8-21

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33321434&oldid=2195240699"